{"pmcid": "PMC11730665", "article_title": "Comparative efficacy and safety of sitagliptin or gliclazide combined with metformin in treatment-naive patients with type 2 diabetes: A single-center, prospective, randomized, controlled, noninferiority study with genetic polymorphism analysis", "ground_truth": ["rs1799853", "rs4664443", "rs7754840", "rs3765467", "rs2285676", "rs2909451", "rs6923761", "rs163184"], "predicted": ["rs163184", "rs1799853", "rs2285676", "rs2909451", "rs3765467", "rs4244285", "rs4664443", "rs4986893", "rs57803087", "rs6923761", "rs756992", "rs7754840", "rs1057910", "CYP2C19*2", "CYP2C19*3", "CYP2C9*2", "CYP2C9*3"], "raw_response": "[\n  \"rs163184\",\n  \"rs1799853\",\n  \"rs2285676\",\n  \"rs2909451\",\n  \"rs3765467\",\n  \"rs4244285\",\n  \"rs4664443\",\n  \"rs4986893\",\n  \"rs57803087\",\n  \"rs6923761\",\n  \"rs756992\",\n  \"rs7754840\",\n  \"rs1057910\",\n  \"CYP2C19*2\",\n  \"CYP2C19*3\",\n  \"CYP2C9*2\",\n  \"CYP2C9*3\"\n]", "had_paper_context": true, "model": "gpt-5.2"}
{"pmcid": "PMC12080641", "article_title": "Sociodemographic, clinical, and genetic factors associated with self-reported antidepressant response outcomes in the UK Biobank", "ground_truth": ["CYP2C19 ultrarapid metabolizer", "CYP2C19 poor metabolizer", "CYP2C19 intermediate metabolizer"], "predicted": ["CYP2C19 poor metabolizer"], "raw_response": "[\n  \"CYP2C19 poor metabolizer\"\n]", "had_paper_context": true, "model": "gpt-5.2"}
{"pmcid": "PMC6347826", "article_title": "Effect of TCF7L2 polymorphism on pancreatic hormones after exenatide in type 2 diabetes", "ground_truth": ["rs7903146"], "predicted": ["rs7903146"], "raw_response": "[\n  \"rs7903146\"\n]", "had_paper_context": true, "model": "gpt-5.2"}
{"pmcid": "PMC11921366", "article_title": "Novel LZTR1 germline mutation as a mechanism of resistance to osimertinib in EGFR-mutated lung adenocarcinoma: a case report", "ground_truth": ["rs1411200130"], "predicted": [], "raw_response": "[]", "had_paper_context": true, "model": "gpt-5.2"}
{"pmcid": "PMC7655626", "article_title": "Pharmacogenetic Interactions of Rifapentine plus Isoniazid with Efavirenz or Nevirapine", "ground_truth": ["NAT2 slow acetylator", "CYP2B6 poor metabolizer"], "predicted": ["CYP2B6 poor metabolizer", "NAT2 slow acetylator", "rs1041983", "rs11045819", "rs11045872", "rs1208", "rs1523130", "rs1799929", "rs1799930", "rs1799931", "rs1801279", "rs1801280", "rs2071197", "rs2291075", "rs28399499", "rs3732360", "rs3745274", "rs4149032", "rs4149056", "rs4149081", "rs4271002", "rs4363657", "rs4646244", "rs4688040", "rs4803419", "rs7643645", "rs776746", "rs887829", "rs10841753", "rs11045879", "CYP2B6*4", "CYP2B6*6", "CYP2B6*22", "NAT2*5", "NAT2*6", "NAT2*7", "NAT2*14"], "raw_response": "[\n  \"CYP2B6 poor metabolizer\",\n  \"NAT2 slow acetylator\",\n  \"rs1041983\",\n  \"rs11045819\",\n  \"rs11045872\",\n  \"rs1208\",\n  \"rs1523130\",\n  \"rs1799929\",\n  \"rs1799930\",\n  \"rs1799931\",\n  \"rs1801279\",\n  \"rs1801280\",\n  \"rs2071197\",\n  \"rs2291075\",\n  \"rs28399499\",\n  \"rs3732360\",\n  \"rs3745274\",\n  \"rs4149032\",\n  \"rs4149056\",\n  \"rs4149081\",\n  \"rs4271002\",\n  \"rs4363657\",\n  \"rs4646244\",\n  \"rs4688040\",\n  \"rs4803419\",\n  \"rs7643645\",\n  \"rs776746\",\n  \"rs887829\",\n  \"rs10841753\",\n  \"rs11045879\",\n  \"CYP2B6*4\",\n  \"CYP2B6*6\",\n  \"CYP2B6*22\",\n  \"NAT2*5\",\n  \"NAT2*6\",\n  \"NAT2*7\",\n  \"NAT2*14\"\n]", "had_paper_context": true, "model": "gpt-5.2"}
